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Neglected Tropical Diseases
More than 1 billion people—one-sixth of the world’s population—
suffer from one or more Neglected Tropical Diseases (NTDs).
NTDs are a group of infectious diseases that are the source  •
of tremendous suffering because of their disfiguring, 
debilitating, and sometimes deadly impact.  In addition to 
causing severe sickness and disability, they compromise 
mental and physical development, contribute to 
malnutrition, reduce school enrollment and hamper 
economic development.
Seven NTDs – lymphatic filariasis (LF), onchocerciasis,  •
schistosomiasis, infections from soil-transmitted helminths 
(hookworm, Ascaris, whipworm), and trachoma, can be 
controlled or even eliminated by providing safe and effective 
medicines to individuals in affected communities through 
mass drug administration (MDA). 
Along with MDA, efforts to control the mosquitoes, blackflies,  •
and other vectors that transmit these diseases, and to 
improve basic water, sanitation, and hygiene are highly 
effective against these NTDs. 
MDA-based programs are considered one of the best buys  •
in public health – with a low cost of about $0.10 to $0.50 
per person/year and the benefit of helping prevent or treat 
several different diseases.
These programs have benefited from donations of  •
medications by major pharmaceutical companies, support 
from the U.S. Government (led by the U.S. Agency for 
International Development), the Bill and Melinda Gates 
Young children in Nigeria gather during evaluation of Guinea 
worm disease prevention and control efforts.
Guinea worm disease (GWD), an NTD for which no treatment 
exists, causes agonizingly painful blisters in the skin when the 
worm slowly exits the body. With country leadership, health 
education, medical management of cases of disease, and 
use of other measures, including simple, low-tech filters for 
drinking water, this devastating disease is now on the verge 
of being eradicated, Nigeria, which had 650,000 infected 
persons per year when the public health program started, 
currently reports none.
Foundation, the Japan International Cooperation Agency, 
and the U.K. Department for International Development, 
among others.
Recent public health successes
Guinea worm disease •  affected some 3.5 million people in 
the 1980s, but in 2009 only 3,200 cases were reported.
Since 2000, more than 2 billion treatments targeting  •
lymphatic filariasis have been delivered, reaching people in 
48 of the 81 countries where the disease is common. 
Onchocerciasis •  has been eliminated in 7 of the 13 major 
areas where the infection was being transmitted in the 
Americas, and the debilitating blindness it causes has been 
prevented throughout much of sub-Saharan Africa.
Blinding  • trachoma has been eliminated from Iran, Mexico, 
Morocco, Oman and the United States; additional countries 
are expected to eliminate this devastating disease.
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CDC and NTDs
For more than 2 decades, CDC has been working to reduce the 
illness, disability, and death caused by NTDs. Together with our 
partners, we help to:
Develop global policy and guidelines for NTD control  •
programs
Conduct research to improve diagnostic and other tools  •
needed to monitor programs
Provide technical assistance to countries and other partners  •
to build capacity and improve programs 
Monitor and evaluate progress towards elimination/control  •
of NTDs
Study additional NTDs to identify and develop better tools  •
and approaches to control and eliminate  them
CDC NTD Research
CDC experts contributed to the science that informs current 
global health policies and programs for NTDs such as LF and 
onchocerciasis.  For example:
Studies conducted by CDC and partners on LF demonstrated  •
that mass treatment with drugs is a safe and effective way to 
control and eliminate NTDs. 
CDC and its partners helped to draft the World Health  •
Organization (WHO) monitoring and evaluation guidelines 
now being used in countries to assess progress of initiatives.
CDC developed and evaluated new tools and approaches to  •
control and eliminate onchocerciasis, LF, and schistosomiasis. 
These tools are being used by several countries, including 
the People’s Republic of China, Morocco, and Togo, to 
document progress and achievement of program goals.
Most recently, CDC researchers demonstrated that LF health  •
education campaigns and morbidity control programs  in 
India can increase adherence with MDA for LF by as much as 
40%. 
Looking towards elimination and eradication
There is still much to be done to help countries start, scale up, 
and regionally coordinate integrated programs. For some NTDs, 
eradication — the permanent elimination of a disease-causing 
organism — is within reach. CDC is working with the WHO, USAID, 
and other partners to provide scientific leadership toward the 
control and elimination of NTDs, by:
Developing more cost-effective tools for mapping, validating  •
coverage, and measuring impact   
Putting into practice a process to stop MDA •
Addressing critical research questions related to integrated  •
programs, interrupting transmission, and ensuring the  
effective use of resources
Developing and evaluating critical diagnostic tools needed  •
for program monitoring and interrupting transmission of LF 
and onchocerciasis
Developing strategies to rapidly detect and respond to any  •
recurrence of disease after MDA is stopped
Integrating NTD programs with other global health efforts. •
For more information, see http://www.cdc.gov/globalhealth/ntd/
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A patient being treated for LF  
in Orissa State, India
CDC and USG Initiatives
The U.S. Global Health Initiative (GHI), announced 
by President Obama in May 2009, represents an 
expanded approach to U.S.  Government-supported 
NTD control and elimination efforts, underscoring 
current activities and emphasizing strategies to 
coordinate NTD and other disease control efforts to 
prevent avoidable deaths and illnesses.
The goals related to NTDs under GHI are to reduce 
the prevalence of seven NTDs by 50 percent 
among 70 percent of the affected population, and to 
contribute to the 1) elimination of onchocerciasis in 
the Americas by 2016, 2) elimination of lymphatic 
filariasis globally by 2020, and the 3) elimination    
of leprosy. 
CDC is a partner in the U.S. Government NTD and 
Global Health Initiatives. Our critical contributions 
include scientific research to guide programs and 
policies, such as the evaluation of a test for LF 
antibodies that will be crucial for knowing when 
transmission of the disease is stopped in Africa. CDC 
is also well poised to provide technical expertise 
related to monitoring and evaluation of program 
efforts to assess progress, and consultation and 
training to Ministries of Health and other partners 
to help build global capacity to control and 
eliminate NTDs.
